QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results 期刊论文 HEPATOLOGY INTERNATIONAL, 2019, 卷号: 13, 期号: 3 作者:  Liang, Xieer;  Gao, Zhiliang;  Xie, Qing;  Zhang, Jiming;  Sheng, Jifang 收藏  |  浏览/下载：46/0  |  提交时间：2019/12/05 Antiviral therapy  Chronic hepatitis B  Long-term tenofovir disoproxil fumarate  Virological suppression   Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China 期刊论文 BMC GASTROENTEROLOGY, 2019, 卷号: 19 作者:  Sun, Jian;  Ding, Huiguo;  Chen, Guofeng;  Wang, Guiqiang;  Wei, Lai 收藏  |  浏览/下载：41/0  |  提交时间：2019/12/05 Chronic hepatitis B  Peg-interferon  Long-term follow-up  Sustained serological response  Sustained combined clinical response   THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文 作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang 收藏  |  浏览/下载：37/0  |  提交时间：2019/12/05 THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文 作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang 收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05